|ABVD||adriamycin, bleomycin, vinblastin, and dacarbazine|
|ACA||Patient Protection and Affordable Care Act|
|ALL||acute lymphoblastic leukemia|
|ASCO||American Society of Clinical Oncology|
|AYA||adolescent and young adult|
Adolescent and Young Adult Health Outcomes and Patient Experience
human homolog B of v-raf (rapidly accelerated fibrosarcoma viral oncogene)
|BRFSS||Behavioral Risk Factors and Surveillance System|
|CCSS||Childhood Cancer Survivor Study|
|CDC||Centers for Disease Control and Prevention|
|CHLA||Children’s Hospital Los Angeles|
|COG||Children’s Oncology Group|
|DCIS||ductal carcinoma in situ|
|HHS||U.S. Department of Health and Human Services|
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 71
Acronyms ABVD adriamycin, bleomycin, vinblastin, and dacarbazine ACA Patient Protection and Affordable Care Act ALL acute lymphoblastic leukemia ASCO American Society of Clinical Oncology AYA adolescent and young adult AYA HOPE Adolescent and Young Adult Health Outcomes and Patient Experience BRAF human homolog B of v-raf (rapidly accelerated fibrosarcoma viral oncogene) BRFSS Behavioral Risk Factors and Surveillance System CCSS Childhood Cancer Survivor Study CDC Centers for Disease Control and Prevention CHLA Children’s Hospital Los Angeles COG Children’s Oncology Group CT computed tomography DCIS ductal carcinoma in situ HHS U.S. Department of Health and Human Services HL Hodgkin’s lymphoma 71
OCR for page 71
72 NEEDS OF ADOLESCENTS AND YOUNG ADULTS WITH CANCER HPV human papillomavirus IDLE indolent lesions of epithelial origin IOM Institute of Medicine LIFE Long-Term Information, Follow-Up and Evaluation MEPS Medical Expenditure Panel Survey MOPP mustragen, oncovin [aka vincristine], procarbazine, and prednisone MRI magnetic resonance imaging NCI National Cancer Institute NCPF National Cancer Policy Forum OHSU Oregon Health & Science University PET positron emission tomography PRG NCI Progress Review Group SEER Surveillance, Epidemiology and End Results TAC Thriving After Cancer UCLA University of California, Los Angeles